Document Type : Original Article
Authors
1
Department of Acupuncture, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2
Department of Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
3
Department of Epidemiology, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract
Background: Trazodone is widely prescribed for primary insomnia, yet several recent appraisals have questioned its suitability as first-line therapy. Acupuncture is increasingly used as an adjunct, but head-to-head comparisons of different acupuncture and acupressure modalities added to pharmacotherapy remain scarce.
Objectives: To compare the effectiveness of body acupuncture, scalp acupuncture, and ear acupressure, each added to trazodone, against trazodone alone in adults with primary insomnia.
Methods: In this single-blind (outcome assessor and statistician), parallel-group, superiority randomized controlled trial, 99 adults with DSM-5–defined primary insomnia (Pittsburgh Sleep Quality Index [PSQI] ≥ 6) were block-randomized (1:1:1:1) to body acupuncture, scalp acupuncture, ear acupressure, or trazodone alone; all groups received trazodone 50 mg nightly. Acupuncture groups received 12 sessions over 4 weeks (ear acupressure: 4 sessions/month). Outcomes—sleep duration (primary), PSQI, and quality of life (WHOQOL-BREF)—were assessed at baseline, week 4, and week 12. Between-group differences were estimated both as raw change-from-baseline scores and as baseline- and age-adjusted mean differences (ANCOVA), each with 95% confidence intervals; standardized effect sizes are additionally reported as Cohen's.
Results: All four groups improved significantly from baseline across all outcomes. Body acupuncture produced the largest and most consistent added benefit. After adjustment for baseline score and age, body acupuncture exceeded trazodone alone at week 4 and week 12 for sleep duration (adjusted mean difference +0.81 h [95% CI 0.53, 1.08] and +1.14 h [0.73, 1.56]), PSQI (−4.41 points [−539, −3.44] and −4.46 [−5.42, −3.50]), and quality of life (+13.3 points [12.4, 14.2] and +8.4 [4.6, 12.2]; all p < 0.001). Scalp acupuncture exceeded trazodone alone for PSQI and quality of life from week 4, and for sleep duration by week 12. Ear acupressure exceeded trazodone alone for PSQI at both time points but not for sleep duration or quality of life. The very large standardized effects (e.g., Cohen's d = 6.68 for quality of life) reflected small within-group standard deviations rather than implausibly large raw differences, and findings were consistent across change-score and adjusted analyses.
Conclusions: Adding body or scalp acupuncture to trazodone produced clinically meaningful improvements in sleep duration, sleep quality, and quality of life beyond trazodone alone in adults with primary insomnia; ear acupressure conferred a more limited, PSQI-specific benefit.
Trial registration: Iranian Registry of Clinical Trials, IRCT20230626058585N2 (registered 2023-06-26; irct.behdasht.gov.ir).
Keywords
Subjects
Acknowledgments: The authors gratefully acknowledge the Vice-Chancellery for Research and Technology of Mashhad University of Medical Sciences for its support of this research, conducted under research project No. 4011325 and Ethics Committee approval IR.MUMS.REC.1405.109.
Availability of data and materials: The dataset presented in this study is available from the corresponding author on reasonable request, during submission or after publication.
Conflicts of interest: The authors declare no conflict of interest.
Consent for publication: Not applicable.
Ethics approval and consent to participate: This study was approved by the Ethics Committee of Mashhad University of Medical Sciences (IR.MUMS.REC.1405.109) and complied with the Declaration of Helsinki. Written informed consent was obtained from all participants before their involvement in the research. The trial was registered in the Iranian Registry of Clinical Trials (IRCT20230626058585N2)
Financial disclosure: The authors have no financial interests to disclose.
Authors’ Contribution: HMF: data collection, intervention delivery, and manuscript drafting. HBT: acupuncture protocol design and supervision. FR: clinical diagnosis, patient screening, and neurological assessment. EMF: study design consultation, statistical analysis, and critical manuscript revision. MZG and HA: intervention delivery and data collection. SKF: study conception and design, acupuncture protocol supervision, and corresponding author. All authors read and approved the final manuscript.
Declaration of AI Use: The authors used an AI-based tool (Claude, Anthropic) for grammar checking, verification of the statistical analyses, and formatting the manuscript to the journal’s guidelines. All content, data, and analyses were reviewed and verified by the authors, who take full responsibility for the accuracy and integrity of the manuscript.
Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/